Regenerex Pharma, Inc. Enters Into Binding Supply and Development Agreement with Holista Colltech Ltd.

(RGPX) LAS VEGAS--(BUSINESS WIRE)--Regenerex Pharma, Inc. (OTC: RGPX), a leading innovator in advanced wound closure systems for chronic wounds, today announced that it has entered into a binding supply and development agreement with Holista Colltech Ltd. of Perth, Australia. Under terms of the agreement, Holista will exclusively manufacture and supply its proprietary ovine collagen, including its patented 300 kDa intact collagen and nano-collagen technologies, for Regenerex’s use in the development,